title: Time-Dependent Regulation of Apoptosis by AEN and BAX in Response to 2-Aminoanthracene Dietary Consumption.
abstract: OBJECTIVE
  The modulation of the toxic effects of 2-aminoanthracene (2AA) on the liver by apoptosis was investigated. Fisher-344 (F344) rats were exposed to various concentrations of 2AA for 14 and 28 days. The arylamine 2AA is an aromatic hydrocarbon employed in manufacturing chemicals, dyes, inks, and it is also a curing agent in epoxy resins and polyurethanes. 2AA has been detected in tobacco smoke and cooked foods.
  
  
  METHODS
  Analysis of total messenger ribonucleic acid (mRNA) extracts from liver for apoptosis-related gene expression changes in apoptosis enhancing nuclease (AEN), Bcl2-associated X protein (BAX), CASP3, Jun proto-oncogene (JUN), murine double minute-2 p53 binding protein homolog (MDM2), tumor protein p53 (p53), and GAPDH genes by quantitative real-time polymerase chain reaction (qRT-PCR) was coupled with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and caspase-3 (Casp3) activity assays.
  
  
  RESULTS
  Specific apoptosis staining result does not seem to show significant difference between control and treated animals. This may be due to freeze-thaw artifacts observed in the liver samples. However, there appears to be a greater level of apoptosis in medium- and high-dose (MD and HD) 2AA treated animals. Analyses of apoptosis-related genes seem to show AEN and BAX as the main targets in the induction of apoptosis in response to 2AA exposure, though p53, MDM2, and JUN may play supporting roles.
  
  
  CONCLUSIONS
  Dose-dependent increases in mRNA expression were observed in all genes except Casp3. BAX was very highly expressed in the HD rats belonging to the 2-week exposure group. This trend was not observed in the animals treated for 4 weeks. Instead, AEN was rather very highly expressed in the liver of the MD animals that were treated with 2AA for 28 days.
authors.affiliation: Department of Chemistry, Georgia Southern University, Statesboro, Georgia, USA.
authors.forename: Worlanyo Eric
authors.initials: WE
authors.lastname: Gato
authors.affiliation: Department of Physiology, Southern Illinois University, Carbondale, School of Medicine, Carbondale, Illinois, USA.
authors.forename: Stacey R
authors.initials: SR
authors.lastname: McGee
authors.affiliation: Department of Physiology, Southern Illinois University, Carbondale, School of Medicine, Carbondale, Illinois, USA.
authors.forename: Dale B
authors.initials: DB
authors.lastname: Hales
authors.affiliation: Bren School of Environmental Science and Management, UC Santa Barbara, Santa Barbara, California, USA.
authors.forename: Jay C
authors.initials: JC
authors.lastname: Means
keywords: 2-aminoanthracene; Bcl2-associated X protein; F344; apoptosis; apoptosis enhancing nuclease; quantitative real-time polymerase chain reaction
references.citation: Mutat Res. 2013 Feb 18;751(1):73-83
references.pmid: 23183053
references.citation: J Anim Sci. 2011 Apr;89(4):916-25
references.pmid: 21415419
references.citation: Toxicol Sci. 2006 Sep;93(1):50-61
references.pmid: 16760417
references.citation: Biomed Environ Sci. 2007 Apr;20(2):146-53
references.pmid: 17624190
references.citation: Blood. 2005 Apr 15;105(8):3263-9
references.pmid: 15613549
references.citation: J Toxicol Sci. 2012;37(5):1001-16
references.pmid: 23038007
references.citation: Science. 2006 Feb 10;311(5762):847-51
references.pmid: 16469926
references.citation: Cancer Res. 2000 Dec 15;60(24):6788-93
references.pmid: 11156366
references.citation: J Exerc Rehabil. 2013 Apr;9(2):212-9
references.pmid: 24278863
references.citation: Biochem Biophys Res Commun. 2005 Nov 11;337(1):39-47
references.pmid: 16171785
references.citation: Leukemia. 2002 Feb;16(2):233-43
references.pmid: 11840290
references.citation: BMJ. 2001 Jun 23;322(7301):1536-8
references.pmid: 11420279
references.citation: Environ Mol Mutagen. 2001;38(4):268-91
references.pmid: 11774358
references.citation: Oncogene. 2008 Jun 19;27(27):3797-810
references.pmid: 18264133
references.citation: J Biol Chem. 2006 Jul 7;281(27):18859-67
references.pmid: 16679323
references.citation: Wei Sheng Yan Jiu. 2010 Mar;39(2):183-6
references.pmid: 20459032
references.citation: Biomed Res Int. 2013;2013:582768
references.pmid: 24151610
references.citation: Anal Chem. 2008 Feb 15;80(4):1192-200
references.pmid: 18189370
references.citation: Dtsch Med Wochenschr. 2013 Jan;138(3):82-6
references.pmid: 23299342
references.citation: J Biol Chem. 2001 Mar 9;276(10):7320-6
references.pmid: 11058599
references.citation: Biochim Biophys Acta. 2002 Mar 14;1602(1):47-59
references.pmid: 11960694
references.citation: EMBO J. 1997 Apr 1;16(7):1695-709
references.pmid: 9130714
references.citation: Toxicol Pathol. 2007 Jun;35(4):495-516
references.pmid: 17562483
references.citation: Annu Rev Pharmacol Toxicol. 2009;49:223-41
references.pmid: 18834305
references.citation: Chem Res Toxicol. 2007 Apr;20(4):662-76
references.pmid: 17381132
references.citation: PLoS One. 2013 Aug 07;8(8):e71553
references.pmid: 23940767
references.citation: Chem Res Toxicol. 2013 Apr 15;26(4):529-37
references.pmid: 23432465
references.citation: Cell Death Differ. 1999 Feb;6(2):99-104
references.pmid: 10200555
references.citation: J Biol Chem. 2004 Nov 12;279(46):48434-42
references.pmid: 15345713
references.citation: Neoplasia. 2012 Dec;14(12):1097-101
references.pmid: 23308042
references.citation: J Steroid Biochem Mol Biol. 2000 Dec 15;75(2-3):91-9
references.pmid: 11226825
references.citation: Nat Rev Cancer. 2008 Feb;8(2):121-32
references.pmid: 18202696
references.citation: Curr Opin Cell Biol. 2009 Dec;21(6):900-12
references.pmid: 19781927
references.citation: Gene. 2000 Jan 25;242(1-2):15-29
references.pmid: 10721693
references.citation: Carcinogenesis. 2000 Mar;21(3):485-95
references.pmid: 10688869
references.citation: Genes Dev. 1996 May 1;10(9):1054-72
references.pmid: 8654922
references.citation: Curr Opin Genet Dev. 2002 Feb;12(1):53-9
references.pmid: 11790555
references.citation: Br J Cancer. 1972 Aug;26(4):239-57
references.pmid: 4561027
references.citation: Nat Rev Cancer. 2002 Sep;2(9):647-56
references.pmid: 12209154
references.citation: Nature. 2003 May 22;423(6938):456-61
references.pmid: 12732850
references.citation: Crit Rev Clin Lab Sci. 2006;43(1):1-67
references.pmid: 16531274
references.citation: Clin Cancer Res. 2005 May 1;11(9):3155-62
references.pmid: 15867207
references.citation: Chem Res Toxicol. 2011 May 16;24(5):698-705
references.pmid: 21480602
references.citation: PLoS One. 2011;6(7):e21796
references.pmid: 21829441